Eye-Net's V2X Collision-Prevention Tech Proves Viable in Large-Scale Bordeaux Trial
Event summary
- Eye-Net, Renault Group, and Orange completed a large-scale live trial of the SafeCycloMove 'Collision Prevention' project in Bordeaux, France, demonstrating positive technical performance in positioning accuracy, ultra-low latency, and scalability.
- The trial integrated Eye-Net’s Software development kit into multiple applications, including Orange’s app, Keolis’ TBM app for cyclists, and Atos’ app installed inside buses.
- Eye-Net’s alerting system was integrated into the TBM Mobility App, enabling real-time data exchange between buses and cyclists to prevent collisions.
- The trial evaluated the performance and reliability of cooperative collision-prevention alerts, collected user feedback, and assessed technical readiness for broader deployment.
- Foresight and its partners are in active commercial discussions to pursue joint commercialization of the solution.
The big picture
The successful trial of Eye-Net’s V2X collision-prevention technology in Bordeaux underscores the growing importance of smart mobility solutions in enhancing urban transportation safety. This collaboration between Foresight, Renault Group, and Orange highlights the strategic shift towards leveraging advanced AI and cellular networks to prevent accidents involving vulnerable road users. The positive results pave the way for broader adoption of such technologies across Europe, potentially reshaping the future of public transportation and road safety.
What we're watching
- Commercialization Pace
- How quickly Foresight and its partners can transition from successful trial results to commercial deployment of the V2X collision-prevention technology.
- Market Expansion
- Whether the technology can be successfully scaled and integrated into other urban transportation networks beyond Bordeaux.
- Partnership Dynamics
- The extent to which the ongoing commercial discussions will lead to long-term strategic alliances with Renault Group, Orange, and other partners.
Related topics
